BioPartnering North America

BioPartnering North America

November 20, 2007 15:06 ET

BioPartnering North America Continues to Attract the Strong Support of Canada's Leading Life Science Associations

LifeSciences British Columbia, BIOTECanada, and BioAlberta enter their 6th year of co-hosting one of North America's most important partnering conferences

SANTA CRUZ, CALIFORNIA--(Marketwire - Nov. 20, 2007) - Technology Vision Group LLC (TVG) is pleased to announce the continued support of leading life science associations LifeSciences British Columbia, BIOTECanada, and BioAlberta for the 6th annual BioPartnering North America conference (BPN), to be held in Vancouver, B.C., Canada, on February 3-5, 2008.

LifeSciences British Columbia supports and represents the biotechnology, medical device, and greater life sciences community of British Columbia through leadership, advocacy and promotion. BIOTECanada is the national, industry-funded association representing the broad spectrum of biotech constituents in Canada, including emerging, established and related service companies in the health, agricultural, and industrial sectors. BioAlberta is the central voice and the organizing hub for the bioindustry in Alberta. Together, they represent the breadth of annual support for BPN from Canadian life science associations on the regional and national level.

BPN is one of the most dynamic life science conferences in the world. Attracting over 900 attendees from nearly 400 international companies from 30 countries, BPN offers an exciting range of opportunities for companies to meet, network and partner with the leading international biotechnology, pharmaceutical, financial and service companies.

Register now for BPN and save 20% off the general registration rate!

Register at:

Pharmaceutical companies may also be eligible to receive two registrations for the price of one! Certain restrictions apply. Contact for details.

BPN offers two unique formats for company presentations that allow companies in various stages of development to showcase their products and technologies in a way that is targeted to their specific partnering needs.

The Emerging Company presentations offer excellent exposure for early stage companies and feature international companies that were founded no later than 2005. This year there will be 22 Emerging Company presentations. Emerging Companies give a 14-minute podium presentation in the main plenary hall with the further opportunity to meet and discuss opportunities in a break out room afterwards.

"This is the best way for a small company to meet potential pharma partners in an organized and efficient way," commented Dr. Richard Davis, CEO of EquinOx Pharmaceuticals.

Open House presentations allow companies to give presentations and meet and hold discussions in their own dedicated booths over a two hour period. Open House Companies also benefit from a 10-minute podium presentation in the main plenary hall. This year there will be 56 Open House presentations.

Opportunities to present at BPN are filling up very quickly, so please apply as soon as possible. Applications to present can be submitted online at:

Optimally Plan for BPN with, the partnering software for BPN, is now live and one-to-one meetings can be arranged on the site beginning December 5, 2007. is a unique and powerful internet resource developed by TVG which helps BPN attendees to optimally plan their meetings and time onsite, as well as target the people they would most like to meet with. facilitates automated meeting scheduling, and includes powerful search tools to help users identify their targets to meet with. also includes time management tools to help attendees manage their time at the conference and ensure that have the best tools to take advantage of all the opportunities at BPN.

Open House and Emerging Company presenters are also able to add a short video to their profile, allowing them to promote their company in dynamic and engaging manner.

For all details about BioPartnering North America please visit:

Conference Sponsors

Platinum Sponsors

AstraZeneca and Province of British Columbia

Gold Sponsors

Burrill & Company, Cooley Godward Kronish LLP, Ferghana Partners Group, and Morrison & Foerster

Silver Sponsors

Farris, Vaughan, Wills & Murphy LLP, Italian Trade Commission, Merck & Co., Inc., Pfizer Inc., PricewaterhouseCoopers, Procter & Gamble Pharmaceuticals, Roche, Seed Intellectual Property Law Group PLLC, UK Trade & Investment, and VWR International

Conference Sponsors

Anapharm, Genome British Columbia and Marsh Canada Ltd.

Conference Supporters

Citigate Dewe Rogerson, MarketWire, and Washington Biotechnology & Biomedical Association (WBBA)

Media Supporters

Bio Business, Biotechnology Focus, BioCentury, BioWorld Today, Contact Canada®, Nature Publishing Group, and European Biopharmaceutical Review

2008 Open House Presenters

Alphora Research Inc., Ambit Biosciences, Apthera, Inc., ASKA Research, Auxilium, Inc., Benitec, Biolex Therapeutics, BioMarck Pharmaceuticals, Ltd., Burnham Institute for Medical Research, Calibrant Biosystems, Inc., CIRION BioPharma Research Inc., ConjuChem Inc., Cook Pharmica LLC, Critical Outcome Technologies, Curalogic A/S, Cytochroma Inc., Cytokinetics, Inc., enGene, Inc., Eurand, Fresenius AG, Ichor Medical Systems, Inc., ImmunoVaccine Technologies Inc., Inimex Pharmaceuticals, Inc., Inovio Biomedical Corp., Inverseon, Inc., Kane Biotech Inc., Laureate Pharma, Inc., NPIL Pharma Torcan, Office of Biomedical Advanced Research and Development Authority (BARDA), Patheon Inc., Perceptronix Medical, Inc., Pharmatek Laboratories, Inc., Plexera Corporation, Quest PharmaTech Inc., Regeron, Inc., Scimega Research Inc., Sensific Technologies Inc., Sidec Technologies AB, Silence Therapeutics AG, Sloning BioTechnology, Stem Cell Therapeutics Corp., SuperGen Inc., Syntaxin Ltd., The Hungarian Investment and Trade Development Agency (ITD Hungary), Tripos Inc., Welichem Biotech Inc., XOMA Ltd., YM BioSciences Inc.

2008 Emerging Company Presenters

NeuroProtect, Inc., OxThera, Pharmexa-Epimmune, Presidio Pharmaceuticals, ProtAffin Biotechnologie AG, Sapphire Therapeutics, Thallion Pharmaceuticals, The Vaccines Company, VentiRx Pharmaceuticals, Inc.

Contact Information